GlassScriptPhysician profile
Alexander Wulff
NPI 1366112724
$162.20
in general payments reported to CMS, 2019-2025
6 companies · $24.47 in 2025
The $24.47 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.98 · 2023: $33.40 · 2024: $82.35 · 2025: $24.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $64.34 | 2024 | Delstrigo, Dificid, Pifeltro |
| Lilly USA, LLC | $24.47 | 2025 | Zepbound, Mounjaro |
| Organon LLC | $21.98 | 2022 | |
| Exact Sciences Corporation | $19.47 | 2023 | Cologuard Collection Kit |
| Regeneron Healthcare Solutions, INC. | $18.01 | 2024 | Dupixent |
| Novo Nordisk INC | $13.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Wulff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.